[1]毛红岩.冠状动脉介入治疗冠心病的疗效及 对患者血清炎症因子的影响[J].医学信息,2018,31(10):77-79.[doi:10.3969/j.issn.1006-1959.2018.10.023]
　MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Journal of Medical Information,2018,31(10):77-79.[doi:10.3969/j.issn.1006-1959.2018.10.023]
点击复制

冠状动脉介入治疗冠心病的疗效及 对患者血清炎症因子的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年10期
页码:
77-79
栏目:
论著
出版日期:
2018-05-15

文章信息/Info

Title:
Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors
文章编号:
1006-1959（2018）10-0077-03
作者:
毛红岩
佳木斯市中心医院心脏内科，黑龙江 佳木斯 154002
Author(s):
MAO Hong-yan
Department of Cardiology,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China
关键词:
PCI; 冠心病; 炎症因子
Keywords:
Key words：PCI; Coronary heart disease; Inflammatory factors
分类号:
R541.4
DOI:
10.3969/j.issn.1006-1959.2018.10.023
文献标志码:
A
摘要:
目的 探讨冠状动脉介入治疗冠心病（CHD）的疗效及对患者血清炎症因子的影响。方法 收集我院自2015年10月~2017年11月收治的CHD患者120例作为观察对象，按治疗方式的不同分为实验组与对照组，每组60例。对照组给予常规药物对症治疗，实验组则给予经皮冠状动脉介入（PCI）治疗，对比两组治疗效果以及治疗前后IL-6、CRP、TNF-α等血清炎症因子变化情况。结果 实验组治疗总有效率为93.33%，高于对照组的78.33%，差异有统计学意义（P＜0.05）。治疗前，两组患者血清炎症因子IL-6、CRP、TNF-α水平比较，差异无统计学意义（P＞0.05）。治疗后7 d，实验组IL-6为（12.14±3.57）pg/L、CRP为（5.40±2.41）mg/L、TNF-α为（9.61±3.12）ng/ml，均分别低于对照组的（14.02±3.64）pg/L、（8.26±2.58）mg/L、（12.28±3.56）ng/ml，差异有统计学意义（P＜0.05）。结论 冠状动脉介入治疗CHD疗效显著，可有效下调患者血清炎症因子水平，促进康复，具有较高的推广价值。
Abstract:
Abstract：Objective To investigate the effect of coronary intervention on coronary heart disease(CHD)and its effect on serum inflammatory factors.Methods A total of 120 patients with CHD admitted to our hospital from October 2015 to November 2017 were collected for observation.According to different treatment methods,the patients were divided into experimental group and control group, with 60 patients in each group.The control group was given symptomatic treatment with conventional drugs.The experimental group was treated with percutaneous coronary intervention(PCI).The effect of treatment and the change of serum inflammatory factors such as IL-6,CRP and TNF-α before and after treatment were compared.Results The total effective rate of the treatment group was 93.33%, which was higher than that of the control group 78.33%,the difference was statistically significant(P<0.05).Before treatment,the levels of serum inflammatory cytokines IL-6,CRP,and TNF-α in the two groups were not statistically different(P>0.05).7 d after treatment, IL-6 in the experimental group was(12.14±3.57)pg/L,CRP was(5.40±2.41)mg/L,and TNF-α was(9.61±3.12)ng/ml,both were significantly lower than the control group(14.02±3.64)pg/L,(8.26±2.58)mg/L,(12.28±3.56)ng/ml,and the difference was statistically significant(P<0.05).Conclusion Coronary interventional therapy for CHD is effective and can effectively reduce the serum inflammatory factor levels and promote rehabilitation.It has a higher value for promotion.

参考文献/References:

[1]时学昆,程璐.老年冠心病患者经桡动脉入路行冠状动脉介入治疗的可行性和安全性[J].中国老年学杂志,2014,34(17):4828-4829.
[2]赵洁,吴俊,贾玫,等.冠心病患者血液脂蛋白相关磷脂酶A2与超敏C反应蛋白及D-二聚体的相关性研究[J].中华检验医学杂志,2014,37(3):227-229.
[3]宋文信,杨成明,曾春雨,等.合并慢性左心衰竭的老年冠心病患者经桡动脉介入治疗的临床评估[J].重庆医学,2010,39(2):191-192.
[4]陈丽芳,宋晓华,黄于朗,等.PCI对冠心病患者血清MMP-9、hs-CRP、HMGB1水平的影响及其预后分析[J].中国实验诊断学,2017,21(10):1714-1717.
[5]罗建军,赖祯平,韦荣耀,等.冠状动脉介入干预对患者血流动力学及血清炎性因子水平的影响[J].中国临床保健杂志,2015,17(4):389-391.
[6]李蕊,王丹丹,苏艳,等.冠心病心绞痛患者经皮冠状动脉介入术后生存质量的影响因素[J].中国老年学杂志,2016,36(10):2379-2380.
[7]马兴瑜.血清超敏C反应蛋白和心肌钙蛋白T检测对冠心病患者经皮冠状动脉介入治疗的临床价值探讨[J].标记免疫分析与临床,2017,24(6):662-665.
[8]杜成林,侯铮,黄骥,等.冠心病患者经皮冠状动脉介入术治疗后血浆IL-12、MCP-1的水平变化[J].医学临床研究,2017,34(1):67-69.
[9]唐秀革.经皮冠状动脉介入治疗老年冠心病临床疗效观察[J].河北医学,2013,19(11):1677-1680.
[10]刘丽军,马燕霞,邵丽荔,等.冠状动脉介入治疗对冠心病血浆高敏C反应蛋白和肿瘤坏死因子α水平的影响[J].心血管康复医学杂志,2013,22(3):230-232.

相似文献/References:

[1]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
　YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Journal of Medical Information,2018,31(10):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[2]张挺挺.经股和桡动脉介入治疗冠心病的临床疗效对比[J].医学信息,2018,31(03):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
　ZHANG Ting-ting.Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery[J].Journal of Medical Information,2018,31(10):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
[3]迮艳华.稳心颗粒联合美托洛尔治疗冠心病心律失常的疗效分析[J].医学信息,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
　ZE Yan-hua.Therapeutic Effect of Wenxin Granule Combined with Metoprolol on Arrhythmia of Coronary Heart Disease[J].Journal of Medical Information,2018,31(10):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
[4]张 旭.冠心病心绞痛患者进行护理干预的临床效果及 对护理质量影响研究[J].医学信息,2018,31(05):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
　ZHANG Xu.Clinical Effect of Nursing Intervention in Patients with Angina Pectoris of Coronary Heart Disease and its Influence on Nursing Quality[J].Journal of Medical Information,2018,31(10):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
[5]向明明,赵晓辉.黑龙江省东部地区汉族人群冠心病的危险因素研究[J].医学信息,2018,31(07):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
　XIANG Ming-ming,ZHAO Xiao-hui.Study on Risk Factors of Coronary Heart Disease in Han Nationality Population in Eastern Heilongjiang Province[J].Journal of Medical Information,2018,31(10):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
[6]王 坤,张永春.血清胆红素水平、单核细胞数、红细胞分布宽度与 冠状动脉病变程度的关系[J].医学信息,2018,31(08):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
　WANG Kun,ZHANG Yong-chun.Relationship between Serum Bilirubin Level,Monocyte Count,Red Blood Cell Distribution Width and Severity of Coronary Artery Disease[J].Journal of Medical Information,2018,31(10):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
[7]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与 冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
　YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Journal of Medical Information,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[8]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
　LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Journal of Medical Information,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[9]田跃雷.冠心病介入治疗后再狭窄的中西医防治[J].医学信息,2022,35(09):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
　TIAN Yue-lei.Prevention and Treatment of Restenosis After Percutaneous Coronary Intervention with Chinese and Western Medicine[J].Journal of Medical Information,2022,35(10):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
[10]李 铎.PCI对慢性稳定性冠心病患者血管内皮功能、 血清hs-CRP水平的影响[J].医学信息,2018,31(12):87.[doi:10.3969/j.issn.1006-1959.2018.12.026]
　LI Duo.Effect of PCI on Vascular Endothelial Function and Serum hs-CRP Levels in Patients with Chronic Stable Coronary Heart Disease[J].Journal of Medical Information,2018,31(10):87.[doi:10.3969/j.issn.1006-1959.2018.12.026]
[11]娄 玥.延续护理对冠心病PCI患者术后康复的应用效果分析[J].医学信息,2019,32(01):181.[doi:10.3969/j.issn.1006-1959.2019.01.059]
　LOU Yue.Analysis of the Effect of Continuous Nursing on Postoperative Rehabilitation of Patients with Coronary Heart Disease Undergoing PCI[J].Journal of Medical Information,2019,32(10):181.[doi:10.3969/j.issn.1006-1959.2019.01.059]

更新日期/Last Update: 2018-05-15